Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PetCure Oncology is a U.S. veterinary oncology company focused on delivering advanced radiation-based cancer care for companion animals, primarily dogs and cats. The company operates a growing network of affiliated cancer treatment centers that provide stereotactic radiosurgery and stereotactic radiation therapy using linear-accelerator-based systems and specialized treatment planning. PetCure combines clinical delivery, care coordination, pet advocacy, and research programs designed to expand access to high-precision radiation oncology in veterinary medicine. Its model partners with leading specialty veterinary hospitals and board-certified oncology specialists across multiple U.S. markets. The company is commercial-stage and has treated thousands of pets through its network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PetCure Oncology.